INFECTIOUS Diagnostics
INFECTIOUS Diagnostics
Current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated. Biogenic sourcing multiple solutions to enhance our offerings in order to automate and facilitate the detection in high medical value area of infection. We have developed multiple solutions to support the detection of SARS-CoV-2 and COVID-19 research. We offer targeted assays, respiratory panels, antibody assays, and tools to support immunobiology and vaccine research. Whether you need targeted assays or panel-based tests, our respiratory portfolio is comprehensive and scalable, allowing you to adjust target selection and sample throughput to meet the needs of your lab. Our portfolio of gastrointestinal panels and targeted assays offer flexibility and improved efficiency by reducing turnaround time, consolidating sample testing, and reducing opportunities for human error. Women’s Health We offer RT-PCR assays that include both antenatal and sexually transmitted infection testing, providing clinicians with reliable results in a clinically relevant timeframe and supporting excellence in women’s health. HAIs Healthcare-associated infections (HAIs) place an enormous burden on patients and the healthcare system. Our HAI assays can help improve patient outcomes by delivering actionable results while simultaneously reducing costs.MOLECULAR INFECTIOUS ARE MOVING TOWARDS HIGH-THROUGHPUT TECHNOLOGY
OUR MULTIPLE SOULTIONS
Coronavirus
Respiratory
Gastrointestinal
09 August 2022
Viewed 9581 times
